Cargando…

Challenge of immune-mediated adverse reactions in the emergency department

Multiple drugs of a new class of cancer treatments called immune checkpoint inhibitors, which work by enabling the immune system to attack tumour cells, have been approved for a variety of indications in recent years. Immune checkpoints, such as cytotoxic T-lymphocyte antigen-4 and programmed death-...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniels, Gregory A, Guerrera, Angela D, Katz, Donna, Viets-Upchurch, Jayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582806/
https://www.ncbi.nlm.nih.gov/pubmed/31113799
http://dx.doi.org/10.1136/emermed-2018-208206

Ejemplares similares